Evidence map›Paper›PMID 31734213›Full record

ArticleJACC. Cardiovascular imaging2020

Prognostic Value of Coronary CTA in Stable Chest Pain: CAD-RADS, CAC, and Cardiovascular Events in PROMISE.

Daniel O Bittner, Thomas Mayrhofer, Matt Budoff, Balint Szilveszter, Borek Foldyna, Travis R Hallett, Alexander Ivanov, Sumbal Janjua, Nandini M Meyersohn, Pedro V Staziaki and 6 more

Open access · greenAbstract readMulticenter Study
In one paragraph

Article in JACC. Cardiovascular imaging, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 57 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
57citing papers in PubMed, 2 pooled it
8.2field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

57 citing papers in PubMed, 2 syntheses or guidelines pooled it, 108 citations in OpenAlex.

  1. Pooled it
  2. Guideline
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Moving towards a uniform diagnosis of coronary artery disease on coronary CTA : Coronary Artery Disease-Reporting and Data System 2.0.Netherlands heart journal : monthly journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation · 2024
    Review
  19. The Role of Cardiac Computed Tomography Angiography in Risk Stratification for Coronary Artery Disease.Journal of the Society for Cardiovascular Angiography & Interventions · 2024
    Review
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors at 7 institutions in 3 countries.

Daniel O BittnerMassachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Friedrich-Alexander University Erlangen-Nürnberg (FAU), Department of Cardiology, Erlangen, Germany. Electronic address: daniel.bittner@uk-erlangen.de.
Thomas MayrhoferMassachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; School of Business Studies, Stralsund University of Applied Sciences, Stralsund, Germany.
Matt BudoffLos Angeles Biomedical Research Institute, Torrance, California.
Balint SzilveszterMassachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; MTA-SE Lendület Cardiovascular Imaging Research Group, Heart and Vascular Centre, Semmelweis University, Budapest, Hungary.
Borek FoldynaMassachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Travis R HallettMassachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Alexander IvanovMassachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Sumbal JanjuaMassachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Nandini M MeyersohnMassachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Pedro V StaziakiMassachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Stephan AchenbachFriedrich-Alexander University Erlangen-Nürnberg (FAU), Department of Cardiology, Erlangen, Germany.
Maros FerencikMassachusetts General Hospital, Harvard Medical School, Boston, Massachusetts; Knight Cardiovascular Institute, Oregon Health and Science University, Portland, Oregon.
Pamela S DouglasDuke Clinical Research Institute, Duke University School of Medicine, Durham, North Carolina.
Udo HoffmannMassachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
Michael T LuMassachusetts General Hospital, Harvard Medical School, Boston, Massachusetts.
PROMISE Investigators
Harvard University · USFriedrich-Alexander-Universität Erlangen-Nürnberg · DEDuke University · USOregon Health & Science University · USSemmelweis University · HUThe Lundquist Institute · USUniversity of Applied Sciences Stralsund · DE

Funding

The impact of HIV viral diversity and cellular immunity on HIV pathogenesisP30AI060354 · NIAID · HARVARD UNIVERSITY (MEDICAL SCHOOL) · PI RAJESH T GANDHI · 2004 to 2026
$94.4M
Clinical and Translational Science Collaborative of ClevelandUL1TR002548 · NCATS · CASE WESTERN RESERVE UNIVERSITY · PI MCCOMSEY, GRACE A · 2018 to 2022
$35.5M
PROMISE Trial: Clinical Coordinating CenterR01HL098237 · NHLBI · DUKE UNIVERSITY · PI DOUGLAS, PAMELA SUSAN · 2009 to 2014
$27.3M
PROMISE Trial: SDCCR01HL098236 · NHLBI · DUKE UNIVERSITY · PI LEE, KERRY L · 2009 to 2014
$5.0M
PROMISE Trial: Dx CoreR01HL098305 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI HOFFMANN, UDO · 2009 to 2014
$3.5M
PROMISE Trial: EQOL Coordinating CenterR01HL098235 · NHLBI · DUKE UNIVERSITY · PI MARK, DANIEL B · 2009 to 2014
$1.6M
Cardiovascular Imaging in Ischemic Heart DiseaseK24HL113128 · NHLBI · MASSACHUSETTS GENERAL HOSPITAL · PI HOFFMANN, UDO · 2012 to 2020
$1.1M
American Heart Association-American Stroke Association 13FTF16450001NCATS NIH HHS UL1 TR002548NHLBI NIH HHS K24 HL113128NHLBI NIH HHS R01 HL098235NHLBI NIH HHS R01 HL098236NHLBI NIH HHS R01 HL098237NHLBI NIH HHS R01 HL098305NIAID NIH HHS P30 AI060354
6 · The paper itself

Abstract

objectivesThe purpose of this study was to compare Coronary Artery Disease Reporting and Data System (CAD-RADS) to traditional stenosis categories and the coronary artery calcium score (CACS) for predicting cardiovascular events in patients with stable chest pain and suspected coronary artery disease (CAD).

backgroundThe 2016 CAD-RADS has been established to standardize the reporting of CAD on coronary CT angiography (CTA).

methodsPROMISE (Prospective Multicenter Imaging Study for Evaluation of Chest Pain) trial participants' CTAs were assessed by a central CT core laboratory for CACS, traditional stenosis-based categories, and modified CAD-RADS grade including high-risk coronary plaque (HRP) features. Traditional stenosis categories and CAD-RADS grade were compared for the prediction of the composite endpoint of death, myocardial infarction, or hospitalization for unstable angina over a median follow-up of 25 months. Incremental prognostic value over traditional risk factors and CACS was assessed.

resultsIn 3,840 eligible patients (mean age: 60.4 ± 8.2 years; 49% men), 3.0% (115) experienced events. CAD-RADS (concordance statistic [C-statistic] 0.747) had significantly higher discriminatory value than traditional stenosis-based assessments (C-statistic 0.698 to 0.717; all p for comparison ≤0.001). With no plaque (CAD-RADS 0) as the baseline, the hazard ratio (HR) for an event increased from 2.43 (95% confidence interval [CI]: 1.16 to 5.08) for CAD-RADS 1 to 21.84 (95% CI: 8.63 to 55.26) for CAD-RADS 4b and 5. In stepwise nested models, CAD-RADS added incremental prognostic value beyond ASCVD risk score and CACS (C-statistic 0.776 vs. 0.682; p < 0.001), and added incremental value persisted in all CACS strata.

conclusionsThese data from a large representative contemporary cohort of patients undergoing coronary CTA for stable chest pain support the prognostic value of CAD-RADS as a standard reporting system for coronary CTA.

Indexed as

Coronary Artery DiseaseAgedAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsChest PainComputed Tomography AngiographyEthnicityFemaleHumansMaleMiddle AgedMinority GroupsPredictive Value of TestsPrognosisProspective StudiesRisk AssessmentAngiotensin-Converting Enzyme InhibitorsAngiotensin Receptor AntagonistsCAD-RADScoronary artery calciumcoronary artery diseasecoronary CT angiographycoronary stenosishigh-risk plaqueprognosis

Identifiers

PMID31734213
PMCPMC7202954
OpenAlexW2988196295

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.